.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Express Scripts
US Army
Cantor Fitzgerald
Julphar
Merck
AstraZeneca
Johnson and Johnson
Deloitte
Federal Trade Commission

Generated: June 25, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,990,100

« Back to Dashboard

Which drugs does patent 5,990,100 protect, and when does it expire?


Patent 5,990,100 protects CLOBEX and TOPICORT and is included in two NDAs. There have been zero Paragraph IV challenges on Clobex and

Summary for Patent: 5,990,100

Title: Composition and method for treatment of psoriasis
Abstract:Pharmaceutical compositions and methods for use in the treatment of psoriasis, having isopropyl myristate as a first active ingredient and a different anti-psoriatic agent as a second active ingredient; preferably they are combined in the same pharmaceutical composition.
Inventor(s): Rosenberg; E. William (Memphis, TN), Glenn; Thomas M. (Mobile, AL), Skinner, Jr.; Robert B. (Memphis, TN), Noah; Patricia W. (Germantown, TN)
Assignee: Panda Pharmaceuticals, L.L.C. (Memphis, TN) The University of Tennessee Research Corporation (Knoxville, TN)
Application Number:09/143,146
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Galderma Labs Lp
CLOBEX
clobetasol propionate
SPRAY;TOPICAL021835-001Oct 27, 2005ATRXYesYes5,990,100► SubscribeY TWICE DAILY TOPICAL TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS.
Taro
TOPICORT
desoximetasone
SPRAY;TOPICAL204141-001Apr 11, 2013ATRXYesYes5,990,100► SubscribeY TREATMENT OF PLAQUE PSORIASIS IN PATIENTS 18 YEARS OF AGE OR OLDER
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 5,990,100

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,886,038 Composition and method for treatment of psoriasis► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
McKinsey
QuintilesIMS
Cantor Fitzgerald
UBS
Farmers Insurance
Argus Health
Colorcon
Baxter
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot